Tizona Therapeutics IPO

tizonatx.com

Tizona Therapeutics is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases.

Founded2015
Total Funding to Date$95.24MM
Register for Details

For more details on financing and valuation for Tizona Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Tizona Therapeutics Ticker Symbol

Tizona Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Tizona Therapeutics Stock Price

The stock price for Tizona Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Tizona Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/15/2019 Series B-3 $173.78MM $XXX.XX $XXX.XX
3/8/2016 Series B and B-2 $151.22MM $XXX.XX $XXX.XX
1/10/2016 Series A $45.36MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Tizona Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM